These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19553788)

  • 1. Combination therapy from the regulatory perspective.
    Markabi S
    Retina; 2009 Jun; 29(6 Suppl):S12-4. PubMed ID: 19553788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery strategies for combination ophthalmic treatments.
    Kuppermann BD
    Retina; 2009 Jun; 29(6 Suppl):S24-6. PubMed ID: 19553793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for combination therapy in age-related macular degeneration.
    Spaide RF
    Retina; 2009 Jun; 29(6 Suppl):S5-7. PubMed ID: 19553803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination angiostatic therapies: current status.
    Peyman GA; Fiscella R; Conway M
    Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
    Busch T
    Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for age-related macular degeneration.
    Patel S
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for drug combinations in age-related macular degeneration.
    Adamis AP
    Retina; 2009 Jun; 29(6 Suppl):S42-4. PubMed ID: 19553800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases.
    Hohman TC
    Retina; 2009 Jun; 29(6 Suppl):S51-3. PubMed ID: 19553804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
    Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of radiation trials for age-related macular degeneration.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S34-5. PubMed ID: 19553797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy using the small interfering RNA bevasiranib.
    Singerman L
    Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology beyond neovascularization: new targets in age-related macular degeneration.
    Heier JS
    Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF and age-related macular degeneration.
    McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
    Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration.
    Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S
    Retina; 2009; 29(10):1450-6. PubMed ID: 19816240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General principles of radiation and chemoradiation.
    Hahn SM; Maity A
    Retina; 2009 Jun; 29(6 Suppl):S30-1. PubMed ID: 19553795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.